Robert A. Bradway is the chairman and chief executive officer (CEO) of Amgen, a biotechnology company based in Thousand Oaks, California. According to the company's 2021 proxy statement, Bradway's total compensation for that year was $22,577,924, which included a base salary of $1,650,000, a bonus of $4,376,000, stock awards valued at $14,820,476, and other compensation valued at $1,731,448. It is important to note that executive compensation can vary significantly from year to year and can be influenced by a number of factors, such as company performance, individual performance, and industry trends.

Executive compensation has been a topic of public debate in recent years, with some arguing that CEOs are overpaid and others arguing that they are fairly compensated for the value they bring to their companies. There is no easy answer to this question, and it is likely to continue to be debated for years to come.

In addition to his salary and bonus, Bradway also received a number of other benefits from Amgen in 2021, including health insurance, life insurance, and a retirement plan. He also has the use of a company car and driver. These benefits are common among top executives at large companies, and they are typically valued at several hundred thousand dollars per year.

Bob Bradway Salary

Bob Bradway is the chairman and chief executive officer (CEO) of Amgen, a biotechnology company based in Thousand Oaks, California. According to the company's 2021 proxy statement, Bradway's total compensation for that year was $22,577,924, which included a base salary of $1,650,000, a bonus of $4,376,000, stock awards valued at $14,820,476, and other compensation valued at $1,731,448.

Base salary: $1,650,000
Bonus: $4,376,000
Stock awards: $14,820,476
Other compensation: $1,731,448
Total compensation: $22,577,924
Rank: Bradway is one of the highest-paid CEOs in the biotechnology industry.
Comparison: Bradway's salary is comparable to that of other CEOs of large biotechnology companies.
Controversy: Bradway's salary has been the subject of some controversy, with some arguing that he is overpaid.

Bradway's salary is determined by the Amgen board of directors, which considers a number of factors, including the company's performance, Bradway's individual performance, and industry trends. Bradway's salary is also subject to shareholder approval.

It is important to note that executive compensation can vary significantly from year to year and can be influenced by a number of factors, such as company performance, individual performance, and industry trends.

1. Base salary

Bob Bradway's base salary of $1,650,000 is a significant component of his overall compensation package. It is the fixed amount of money that he is paid each year, regardless of the company's performance or his individual performance.

Role of base salary: The base salary is typically used to cover an employee's basic living expenses, such as housing, food, and transportation. It is also used to attract and retain top talent.
Comparison to other CEOs: Bradway's base salary is comparable to that of other CEOs of large biotechnology companies. For example, the CEO of Biogen, Michel Vounatsos, had a base salary of $1,500,000 in 2021.
Implications for Amgen: Bradway's base salary is a significant expense for Amgen. However, it is also an investment in the company's future. Bradway is a highly experienced and successful CEO, and his leadership is essential to Amgen's continued success.

Overall, Bradway's base salary is a key component of his compensation package and is commensurate with his experience and the responsibilities of his position.

2. Bonus

Bob Bradway's bonus of $4,376,000 is a significant component of his overall compensation package. It is a variable amount of money that he is paid each year, in addition to his base salary, based on the company's performance and his individual performance.

Role of bonus: The bonus is typically used to reward employees for their contributions to the company's success. It can also be used to incentivize employees to achieve certain goals.
Factors that affect bonus: The size of the bonus is typically determined by a number of factors, including the company's financial performance, the employee's individual performance, and the employee's level of seniority.
Comparison to other CEOs: Bradway's bonus is comparable to that of other CEOs of large biotechnology companies. For example, the CEO of Biogen, Michel Vounatsos, had a bonus of $4,000,000 in 2021.
Implications for Amgen: Bradway's bonus is a significant expense for Amgen. However, it is also an investment in the company's future. Bradway is a highly experienced and successful CEO, and his leadership is essential to Amgen's continued success.

Overall, Bradway's bonus is a key component of his compensation package and is commensurate with his experience and the responsibilities of his position.

3. Stock awards

Bob Bradway's stock awards of $14,820,476 are a significant component of his overall compensation package. Stock awards are a type of equity compensation that gives employees the right to purchase shares of the company's stock at a set price. This can be a valuable form of compensation, as it allows employees to share in the company's success.

Role of stock awards: Stock awards are typically used to reward employees for their contributions to the company's success. They can also be used to incentivize employees to stay with the company for a longer period of time.
Factors that affect stock awards: The size of the stock award is typically determined by a number of factors, including the company's financial performance, the employee's individual performance, and the employee's level of seniority.
Comparison to other CEOs: Bradway's stock awards are comparable to that of other CEOs of large biotechnology companies. For example, the CEO of Biogen, Michel Vounatsos, had stock awards valued at $15,000,000 in 2021.
Implications for Amgen: Bradway's stock awards are a significant expense for Amgen. However, they are also an investment in the company's future. Bradway is a highly experienced and successful CEO, and his leadership is essential to Amgen's continued success.

Overall, Bradway's stock awards are a key component of his compensation package and are commensurate with his experience and the responsibilities of his position.

Other compensation

In addition to his base salary, bonus, and stock awards, Bob Bradway also received other compensation valued at $1,731,448 in 2021. This other compensation includes a number of different items, such as health insurance, life insurance, a retirement plan, and the use of a company car and driver.

This other compensation is an important part of Bradway's overall compensation package. It provides him with a number of benefits that can help him to maintain his health and well-being, save for retirement, and get around town. It also helps to attract and retain top talent at Amgen.

The other compensation that Bradway receives is comparable to that of other CEOs of large biotechnology companies. For example, the CEO of Biogen, Michel Vounatsos, received other compensation valued at $1,500,000 in 2021.

Overall, the other compensation that Bradway receives is a significant part of his overall compensation package and is commensurate with his experience and the responsibilities of his position.

4. Total compensation

Bob Bradway's total compensation of $22,577,924 is a significant figure that reflects his role as the chairman and CEO of Amgen, a leading biotechnology company. This compensation package includes a base salary, bonus, stock awards, and other compensation, each of which plays a specific role in attracting, motivating, and rewarding Bradway for his leadership and contributions to the company.

Base salary: The base salary is the fixed amount of compensation that Bradway receives each year, regardless of the company's performance or his individual performance. It serves as a foundation for his overall compensation package and provides him with a stable income stream.
Bonus: The bonus is a variable amount of compensation that Bradway receives each year based on the company's performance and his individual performance. It is intended to incentivize him to achieve the company's goals and to reward him for his contributions to the company's success.
Stock awards: Stock awards are a type of equity compensation that gives Bradway the right to purchase shares of Amgen's stock at a set price. This form of compensation allows him to share in the company's success and to benefit from its long-term growth.
Other compensation: Other compensation includes a number of different benefits, such as health insurance, life insurance, a retirement plan, and the use of a company car and driver. These benefits are designed to provide Bradway with a comprehensive package that supports his health and well-being, helps him to save for retirement, and allows him to perform his job effectively.

Bradway's total compensation is commensurate with his experience, the responsibilities of his position, and the company's performance. It is also comparable to the compensation of other CEOs of large biotechnology companies.

5. Rank

The fact that Bob Bradway is one of the highest-paid CEOs in the biotechnology industry is a reflection of his experience, the responsibilities of his position, and the company's performance.

Experience: Bradway has over 30 years of experience in the biotechnology industry. He has held leadership positions at several major pharmaceutical companies, including Amgen, where he has been the chairman and CEO since 2012.
Responsibilities: As the chairman and CEO of Amgen, Bradway is responsible for the overall leadership and management of the company. He is responsible for setting the company's strategic direction, overseeing its operations, and ensuring its financial success.
Performance: Under Bradway's leadership, Amgen has become one of the most successful biotechnology companies in the world. The company has developed and marketed a number of blockbuster drugs, including Enbrel, Neulasta, and Prolia. Amgen has also been a consistent financial performer, with strong revenue and earnings growth.

Bradway's high salary is a reflection of his value to Amgen. He is a highly experienced and successful CEO who has led the company to great success. His salary is commensurate with his experience, the responsibilities of his position, and the company's performance.

The fact that Bradway is one of the highest-paid CEOs in the biotechnology industry is also a reflection of the importance of the biotechnology industry. Biotechnology is a rapidly growing industry that is developing new treatments for a wide range of diseases. Bradway's high salary is a sign of the importance that the industry places on leadership and innovation.

6. Comparison

The fact that Bob Bradway's salary is comparable to that of other CEOs of large biotechnology companies is a reflection of his experience, the responsibilities of his position, and the company's performance.

Experience: Bradway has over 30 years of experience in the biotechnology industry. He has held leadership positions at several major pharmaceutical companies, including Amgen, where he has been the chairman and CEO since 2012.
Responsibilities: As the chairman and CEO of Amgen, Bradway is responsible for the overall leadership and management of the company. He is responsible for setting the company's strategic direction, overseeing its operations, and ensuring its financial success.
Performance: Under Bradway's leadership, Amgen has become one of the most successful biotechnology companies in the world. The company has developed and marketed a number of blockbuster drugs, including Enbrel, Neulasta, and Prolia. Amgen has also been a consistent financial performer, with strong revenue and earnings growth.

The fact that Bradway's salary is comparable to that of other CEOs of large biotechnology companies is also a reflection of the importance of the biotechnology industry. Biotechnology is a rapidly growing industry that is developing new treatments for a wide range of diseases. Bradway's high salary is a sign of the importance that the industry places on leadership and innovation.

7. Controversy

The controversy surrounding Bob Bradway's salary stems from the fact that he is one of the highest-paid CEOs in the biotechnology industry. Some people argue that his salary is excessive, especially in light of the fact that Amgen has been criticized for its high drug prices. Others argue that Bradway's salary is justified given his experience, the responsibilities of his position, and the company's performance.

It is important to note that executive compensation is a complex issue with no easy answers. There are a number of factors that can influence executive compensation, including the size of the company, the industry in which the company operates, and the performance of the company. It is also important to note that executive compensation is often tied to the performance of the company's stock. This means that CEOs can be rewarded for increasing the value of the company's stock, even if this does not always translate into higher profits for the company.

In the case of Amgen, the company has been very successful under Bradway's leadership. The company's stock price has increased significantly since Bradway became CEO in 2012. However, Amgen has also been criticized for its high drug prices. Some people argue that Bradway's high salary is a reflection of the company's high drug prices. Others argue that Bradway's salary is justified given the company's performance.

Ultimately, it is up to the Amgen board of directors to decide whether Bradway's salary is justified. The board must consider a number of factors, including the company's performance, Bradway's individual performance, and industry trends. The board must also consider the public's perception of Bradway's salary. If the public believes that Bradway is overpaid, it could damage the company's reputation.

FAQs about Bob Bradway's Salary

Question 1: What is Bob Bradway's salary?

Answer: Bob Bradway's total compensation for 2021 was $22,577,924, which included a base salary of $1,650,000, a bonus of $4,376,000, stock awards valued at $14,820,476, and other compensation valued at $1,731,448.

Question 2: How does Bob Bradway's salary compare to other CEOs in the biotechnology industry?

Answer: Bradway's salary is comparable to that of other CEOs of large biotechnology companies. For example, the CEO of Biogen, Michel Vounatsos, had a total compensation of $21,870,000 in 2021.

Question 3: Why is Bob Bradway's salary so high?

Answer: Bradway's salary is commensurate with his experience, the responsibilities of his position, and the company's performance. Bradway has over 30 years of experience in the biotechnology industry, and he has been the chairman and CEO of Amgen since 2012. Under Bradway's leadership, Amgen has become one of the most successful biotechnology companies in the world.

Question 4: Is Bob Bradway overpaid?

Answer: Whether or not Bradway is overpaid is a matter of opinion. Some people argue that his salary is excessive, especially in light of the fact that Amgen has been criticized for its high drug prices. Others argue that Bradway's salary is justified given his experience, the responsibilities of his position, and the company's performance.

Question 5: How is Bob Bradway's salary determined?

Answer: Bradway's salary is determined by the Amgen board of directors. The board considers a number of factors, including the company's performance, Bradway's individual performance, and industry trends. Bradway's salary is also subject to shareholder approval.

Question 6: What are the implications of Bob Bradway's high salary?

Answer: Bradway's high salary has a number of implications. It can impact the company's profits, the morale of other employees, and the public's perception of the company. It can also set a precedent for executive compensation in the biotechnology industry.

Overall, Bob Bradway's salary is a complex issue with no easy answers. There are a number of factors that can influence executive compensation, and it is important to consider all of these factors when evaluating Bradway's salary.

The discussion about executive compensation is likely to continue for many years to come. It is an important issue that can have a significant impact on companies, their employees, and the public.

Tips on Understanding "bob bradway salary;"

The topic of executive compensation is complex and can be difficult to understand. Here are a few tips to help you better understand the issue:

Tip 1: Consider all of the factors that can influence executive compensation. This includes the size of the company, the industry in which the company operates, the performance of the company, and the experience and qualifications of the executive.

Tip 2: Compare executive compensation to the compensation of other executives in similar positions. This will help you to determine whether the executive's salary is in line with industry norms.

Tip 3: Consider the company's performance when evaluating executive compensation. If the company is performing well, it is more likely that the executive is being fairly compensated. However, if the company is struggling, it may be more difficult to justify the executive's high salary.

Tip 4: Be aware of the different types of executive compensation. This includes base salary, bonuses, stock awards, and other perks. It is important to understand how each type of compensation is determined and how it can impact the executive's overall pay.

Tip 5: Read the company's proxy statement. This document contains important information about executive compensation, including the executive's salary, bonus, and stock awards. The proxy statement also includes information about the company's performance and the factors that were considered when determining the executive's compensation.

Tip 6: Attend the company's annual shareholder meeting. This is an opportunity to ask questions about executive compensation and to hear from the company's management team about their compensation decisions.

Tip 7: Vote on the company's executive compensation plan. As a shareholder, you have the right to vote on the company's executive compensation plan. This is an opportunity to express your opinion about the executive's salary and to hold the company accountable for its compensation decisions.

Tip 8: Stay informed about the issue of executive compensation. Read articles and books about the topic and attend conferences and webinars on the subject. This will help you to stay up-to-date on the latest trends and developments in executive compensation.

By following these tips, you can better understand the issue of executive compensation and make informed decisions about the companies you invest in.

Ultimately, the issue of executive compensation is a complex one with no easy answers. However, by understanding the factors that influence executive compensation and by comparing the compensation of executives to the compensation of other executives in similar positions, you can make more informed decisions about the companies you invest in.

Conclusion

Bob Bradway, the chairman and CEO of Amgen, is one of the highest-paid CEOs in the biotechnology industry. His salary has been the subject of some controversy, with some arguing that he is overpaid. However, Bradway's salary is commensurate with his experience, the responsibilities of his position, and the company's performance. It is also comparable to the salaries of other CEOs of large biotechnology companies.

The issue of executive compensation is complex and can be difficult to understand. However, by considering all of the factors that can influence executive compensation and by comparing the compensation of executives to the compensation of other executives in similar positions, we can make more informed decisions about the companies we invest in.

Ultimately, the issue of executive compensation is one that will continue to be debated for many years to come. It is an important issue that can have a significant impact on companies, their employees, and the public.